Related Experiment Video
Updated: Aug 2, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Time requirements for perioperative glucose management using fully closed-loop versus standard insulin therapy: A
Jonathan Roos1, Daniel Schürch1, Andreas Frei2
1Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Fully automated closed-loop (FCL) insulin therapy significantly reduces staff time for perioperative glucose management compared to standard insulin therapy. This technology offers potential workload relief for diabetes management in hospitals.
Area of Science:
- Endocrinology
- Medical Technology
- Surgical Care
Background:
- Perioperative glucose management is critical for surgical patients.
- Standard insulin therapy requires significant staff time and resources.
- Optimizing glucose control protocols can improve patient outcomes and resource allocation.
Purpose of the Study:
- To compare the time demands of perioperative glucose management between fully automated closed-loop (FCL) insulin therapy and standard insulin therapy.
- To quantify the staff time required for blood glucose management across different perioperative care settings.
Main Methods:
- A time-motion study was conducted using theoretical scenarios for elective minor and major abdominal surgeries.
- Staff workflows and task durations for FCL and standard insulin therapy were measured.
- Cumulative staff time was calculated based on task frequency and average duration.
Main Results:
- FCL insulin therapy substantially reduced the time for perioperative glucose management compared to standard therapy (2.1–4.5 times less).
- For major abdominal surgery, FCL required 248.5 min versus 753.9 min for standard therapy.
- For minor abdominal surgery, FCL required 68.6 min versus 133.2 min for standard therapy.
Conclusions:
- Fully automated closed-loop insulin delivery can significantly decrease the workload associated with inpatient glucose management.
- This technology has the potential to alleviate staff burden in diabetes care settings.
- Implementation requires adequately trained staff to maximize benefits.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: Glinides
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

